Global Patent Index - EP 1094806 A2

EP 1094806 A2 2001-05-02 - VASCULOPROTECTOR

Title (en)

VASCULOPROTECTOR

Title (de)

SCHUTZMITTEL DER VASCULATUR

Title (fr)

VASCULOPROTECTEUR

Publication

EP 1094806 A2 (EN)

Application

EP 99929579 A

Priority

  • GB 9902157 W
  • GB 9814620 A

Abstract (en)

[origin: WO0001716A2] The invention relates to a method of inducing a vasculoprotective effect, particularly relating to restonosis, angioplasty, chronic allograft rejection, diabetic angiopathy, autoimmune angiopathy, ateriosclerosis and atherosclerosis in a subject, the method comprising treating the subject with an ERbeta agonist. The preferred Estrogen Receptor beta agonist is genistein.

[origin: WO0001716A2] The invention relates to a method of inducing a vasculoprotective effect in a subject, the method comprising treating the subject with an ER beta agonist.

IPC 1-7 (main, further and additional classification)

A61K 31/35; C12N 5/06

IPC 8 full level (invention and additional information)

C12N 5/10 (2006.01); A61K 31/352 (2006.01); A61K 31/439 (2006.01); A61K 45/00 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 37/06 (2006.01); C07D 471/22 (2006.01)

CPC (invention and additional information)

A61K 31/352 (2013.01)

Citation (search report)

See references of WO 0001716A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0001716 A2 20000113; WO 0001716 A3 20001005; AU 4636499 A 20000124; CA 2331885 A1 20000113; EP 1094806 A2 20010502; GB 9814620 D0 19980902; JP 2002519435 A 20020702

INPADOC legal status


2006-05-03 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20051025

2005-06-01 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20050413

2001-05-02 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010115

2001-05-02 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE